Regulation of cholesterol homeostasis by liver X receptors

Clinica Chimica Acta

Volumn 411, Issue 9-10, 2010, Pages 617-625

  Hu, Yan Wei ^a   Zheng, Lei ^a   Wang, Qian ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Cholesterol homeostasis; HDL; LXRs; RCT

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ABC TRANSPORTER G1; ABC TRANSPORTER G5; ABC TRANSPORTER G8; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; APOLIPOPROTEIN M; CHOLESTEROL ESTER TRANSFER PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; LOW DENSITY LIPOPROTEIN RECEPTOR; LXR 623; MEMBRANE PROTEIN; NIEMANN PICK C 1 LIKE 1 PROTEIN; NIEMANN PICK C 1 PROTEIN; NIEMANN PICK C 2 PROTEIN; OXYSTEROL; PHOSPHOLIPID TRANSFER PROTEIN; SCAVENGER RECEPTOR B; STEROID 17ALPHA MONOOXYGENASE; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; BILE ACID SYNTHESIS; CARDIOVASCULAR DISEASE; CHOLESTEROL INTAKE; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LIPOGENESIS; METABOLIC REGULATION; NIEMANN PICK DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CHOLESTEROL; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; ORPHAN NUCLEAR RECEPTORS;

EID: 77950461242     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.12.027     Document Type: Review

References (100)

1. McGovern P.G., Pankow J.S., Shahar E., Doliszny K.M., Folsom A.R., Blackburn H., Luepker R.V. Recent trends in acute coronary heart disease-mortality, morbidity, medical care, and risk factors. N Engl J Med 1996, 334:884-890. The Minnesota Heart Survey Investigators.
2. Wilhelmsen L., Rosengren A., Johansson S., Lappas G. Coronary heart disease attack rate, incidence and mortality 1975-1994 in Göteborg, Sweden. Eur Heart J 1997, 18:572-581.
3. Davidson M.H. Overview of prevention and treatment of atherosclerosis with lipid-altering therapy for pharmacy directors. Am J Manag Care 2007, 13(Suppl 10):S260-269.
4. Tavridou A., Manolopoulos V.G. Novel molecules targeting dyslipidemia and atherosclerosis. Curr Med Chem 2008, 15:792-802.
5. Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest 2002, 110:905-911.
6. Fielding C.J., Fielding P.E. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995, 36:211-928.
7. Prüfer K., Boudreaux J. Nuclear localization of liver X receptor alpha and beta is differentially regulated. J Cell Biochem 2007, 100:69-85.
8. Fan X., Kim H.J., Bouton D., Warner M., Gustafsson J.A. Expression of liver X receptor beta is essential for formation of superficial cortical layers and migration of later-born neurons. Proc Natl Acad Sci U S A 2008, 105:13445-13450.
9. Gabbi C., Warner M., Gustafsson J.A. Minireview: liver X receptor beta: emerging roles in physiology and diseases. Mol Endocrinol 2009, 23:129-136.
10. Janowski B.A., Grogan M.J., Jones S.A., Wisely G.B., Kliewer S.A., Corey E.J., et al. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci U S A 1999, 96:266-271.
11. Collins J.L., Fivush A.M., Watson M.A., Galardi C.M., Lewis M.C., Moore L.B., et al. Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J Med Chem 2002, 45:1963-1966.
12. Schultz J.R., Tu H., Luk A., Repa J.J., Medina J.C., Li L., et al. Role of LXRs in control of lipogenesis. Genes Dev 2000, 14:2831-2838.
13. Song C., Hiipakka R.A., Liao S. Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs. Steroids 2000, 65:423-427.
14. Molteni V., Li X., Nabakka J., Liang F., Wityak J., Koder A., et al. N-Acylthiadiazolines, a new class of liver X receptor agonists with selectivity for LXRbeta. Med Chem 2007, 50:4255-4259.
15. Repa J.J., Mangelsdorf D.J. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 2000, 16:459-481.
16. Janowski B.A., Willy P.J., Devi T.R., Falck J.R., Mangelsdorf D.J. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996, 383:728-731.
17. Lehmann J.M., Kliewer S.A., Moore L.B., Smith-Oliver T.A., Oliver B.B., Su J.L., et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 1997, 272:3137-3140.
18. Fiévet C., Staels B. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis. Biochem Pharmacol 2009, 77:1316-1327.
19. Dean M., Hamon Y., Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 2001, 42:1007-1017.
20. Oram J.F., Vaughan A.M. ATP-binding cassette cholesterol transporters and cardiovascular disease. Circ Res 2006, 99:1031-1043.
21. Oram J.F., Heinecke J.W. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 2005, 85:1343-1372.
22. Schuster G.U., Parini P., Wang L., Alberti S., Steffensen K.R., Hansson G.K., et al. Accumulation of foam cells in liver X receptor-deficient mice. Circulation 2002, 106:1147-1153.
23. Wong J., Quinn C.M., Brown A.J. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR. Biochem J 2006, 400:485-491.
24. Wu J., Zhang Y., Wang N., Davis L., Yang G., Wang X., et al. Liver X receptor-alpha mediates cholesterol efflux in glomerular mesangial cells. Am J Physiol Renal Physiol 2004, 287:F886-895.
25. Thymiakou E., Zannis V.I., Kardassis D. Physical and functional interactions between liver X receptor/retinoid X receptor and Sp1 modulate the transcriptional induction of the human ATP binding cassette transporter A1 gene by oxysterols and retinoids. Biochemistry 2007, 46:11473-11483.
26. Zhao S.P., Dong S.Z. Effect of tumor necrosis factor alpha on cholesterol efflux in adipocytes. Clin Chim Acta 2008, 389:67-71.
27. Nakaya K., Ayaori M., Hisada T., Sawada S., Tanaka N., Iwamoto N., et al. Telmisartan enhances cholesterol efflux from THP-1 macrophages by activating PPARgamma. J Atheroscler Thromb 2007, 14:133-141.
28. Qiu G., Hill J.S. Atorvastatin inhibits ABCA1 expression and cholesterol efflux in THP-1 macrophages by an LXR-dependent pathway. J Cardiovasc Pharmacol 2008, 51:388-395.
29. Hozoji M., Munehira Y., Ikeda Y., Makishima M., Matsuo M., Kioka N., et al. Direct interaction of nuclear liver X receptor-beta with ABCA1 modulates cholesterol efflux. J Biol Chem 2008, 283:30057-30063.
30. Baldán A., Tarr P., Lee R., Edwards P.A. ATP-binding cassette transporter G1 and lipid homeostasis. Curr Opin Lipidol 2006, 17:227-232.
31. Sabol S.L., Brewer H.B., Santamarina-Fojo S. The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver. J Lipid Res 2005, 46:2151-2167.
32. Mouzat K., Prod'homme M., Volle D.H., Sion B., Déchelotte P., Gauthier K., et al. Oxysterol nuclear receptor LXRbeta regulates cholesterol homeostasis and contractile function in mouse uterus. J Biol Chem 2007, 282:4693-4701.
33. Quinet E.M., Basso M.D., Halpern A.R., Yates D.W., Sheffan R.J., Clerin V., et al. LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse. J Lipid Res 2009, Epub ahead of print.
34. Katz A., Udata C., Ott E., Hickey L., Burczynski M.E., Burghart P., et al. Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants. J Clin Pharmacol 2009, 49:643-649.
35. DiBlasio-Smith E.A., Arai M., Quinet E.M., Evans M.J., Kornaga T., Basso M.D., et al. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells. J Transl Med 2008, 6:59.
36. Aravindhan K., Webb C.L., Jaye M., Ghosh A., Willette R.N., DiNardo N.J., et al. Assessing the effects of LXR agonists on cellular cholesterol handling: a stable isotope tracer study. J Lipid Res 2006, 47:1250-1260.
37. Peng D., Hiipakka R.A., Dai Q., Guo J., Reardon C.A., Getz G.S., et al. Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice. J Pharmacol Exp Ther 2008, 327:332-342.
38. Stefulj J., Panzenboeck U., Becker T., Hirschmugl B., Schweinzer C., Lang I., et al. Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1. Circ Res 2009, 104:600-608.
39. Yu L., Hammer R.E., Li-Hawkins J., Von Bergmann K., Lutjohann D., Cohen J.C., et al. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci U S A 2002, 99:16237-16242.
40. Repa J.J., Berge K.E., Pomajzl C., Richardson J.A., Hobbs H., Mangelsdorf D.J. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 2002, 277:18793-18800.
41. Yu L., York J., von Bergmann K., Lutjohann D., Cohen J.C., Hobbs H.H. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J Biol Chem 2003, 278:15565-15570.
42. Calpe-Berdiel L., Rotllan N., Fiévet C., Roig R., Blanco-Vaca F., Escolà-Gil J.C. Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8. J Lipid Res 2008, 49:1904-1911.
43. Berge K.E., Tian H., Graf G.A., Yu L., Grishin N.V., Schultz J., et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000, 290:1771-1775.
44. Tang Y, Li H, Liu JP Niemann-Pick disease type C: from molecule to clinic. Clin Exp Pharmacol Physiol 2009, Epub ahead of print.
45. Carstea E.D., Morris J.A., Coleman K.G., Loftus S.K., Zhang D., Cummings C., et al. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 1997, 277:228-231.
46. Naureckiene S., Sleat D.E., Lackland H., Fensom A., Vanier M.T., Wattiaux R., et al. Identification of HE1 as the second gene of Niemann-Pick C disease. Science 2000, 290:2298-2301.
47. Liou H.L., Dixit S.S., Xu S., Tint G.S., Stock A.M., Lobel P. NPC2, the protein deficient in Niemann-Pick C2 disease, consists of multiple glycoforms that bind a variety of sterols. J Biol Chem 2006, 281. 36710-3623.
48. Cheruku S.R., Xu Z., Dutia R., Lobel P., Storch J. Mechanism of cholesterol transfer from the Niemann-Pick type C2 protein to model membranes supports a role in lysosomal cholesterol transport. J Biol Chem 2006, 281:31594-31604.
49. Altmann S.W., Davis H.R., Zhu L.J., Yao X., Hoos L.M., Tetzloff G., et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 2004, 303:1201-1204.
50. Rigamonti E., Helin L., Lestavel S., Mutka A.L., Lepore M., Fontaine C., et al. Liver X receptor activation controls intracellular cholesterol trafficking and esterification in human macrophages. Circ Res 2005, 97:682-689.
51. Ou X., Dai X., Long Z., Tang Y., Cao D., Hao X., et al. Liver X receptor agonist T0901317 reduces atherosclerotic lesions in apoE-/- mice by up-regulating NPC1 expression. Sci China C Life Sci 2008, 51:418-429.
52. Dai X.Y., Ou X., Hao X.R., Cao D.L., Tang Y.L., Hu Y.W., et al. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice. J Cardiovasc Pharmacol 2008, 51:467-475.
53. Ma X., Hu Y.W., Mo Z.C., Li X.X., Liu X.H., Xiao J., et al. NO-1886 up-regulates Niemann-Pick C1 protein (NPC1) expression through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells. Cardiovasc Drugs Ther 2009, 23:199-206.
54. Iqbal J., Hussain M.M. Intestinal lipid absorption. Am J Physiol Endocrinol Metab 2009, 296(6):E1183-1194.
55. Tang W., Ma Y., Jia L., Ioannou Y.A., Davies J.P., Yu L. Niemann-Pick C1-like 1 is required for an LXR agonist to raise plasma HDL cholesterol in mice. Arterioscler Thromb Vasc Biol 2008, 28:448-454.
56. Duval C., Touche V., Tailleux A., Fruchart J.C., Fievet C., Clavey V., et al. Niemann-Pick C1 like 1 gene expression is downregulated by LXR activators in the intestine. Biochem Biophys Res Commun 2006, 340:1259-1263.
57. Alvaro A, Rosales R, Masana L, Vallvé JC Polyunsaturated fatty acids down-regulate in vitro expression of the key intestinal cholesterol absorption protein NPC1L1: no effect of monounsaturated nor saturated fatty acids. J Nutr Biochem 2009, Epub ahead of print.
58. Mahley R.W., Innerarity T.L., Rall S.C., Weisgraber K.H. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 1984, 25:1277-1294.
59. Rubin E.M., Krauss R.M., Spangler E.A., Verstuyft J.G., Clift S.M. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 1991, 353:265-267.
60. Mahley RW Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988, 240:622-630.
61. Dahlbäck B, Nielsen LB Apolipoprotein M: a novel player in high-density lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol 2006, 17:291-295.
62. Sato M., Kawata Y., Erami K., Ikeda I., Imaizumir K. LXR agonist increases the lymph HDL transport in rats by promoting reciprocally intestinal ABCA1 and apo A-I mRNA levels. Lipids 2008, 43:125-131.
63. Lee J., Tauscher A., Seo D.W., Oram J.F., Kuver R. Cultured gallbladder epithelial cells synthesize apolipoproteins A-I and E. Am J Physiol Gastrointest Liver Physiol 2003, 285:G630-641.
64. Gentili C., Tutolo G., Pianezzi A., Cancedda R. Descalzi Cancedda F. Cholesterol secretion and homeostasis in chondrocytes: a liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein A1 expression. Matrix Biol 2005, 24:35-44.
65. Huuskonen J., Vishnu M., Chau P., Fielding P.E., Fielding C.J. Liver X receptor inhibits the synthesis and secretion of apolipoprotein A1 by human liver-derived cells. Biochemistry 2006, 45:15068-15074.
66. Plump A.S., Smith J.D., Hayek T., Aalto-Setälä K., Walsh A., Verstuyft J.G., et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992, 71:343-353.
67. Lin C.Y., Duan H., Mazzone T. Apolipoprotein E-dependent cholesterol efflux from macrophages: kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E. J Lipid Res 1999, 40:1618-1627.
68. Laffitte B.A., Repa J.J., Joseph S.B., Wilpitz D.C., Kast H.R., Mangelsdorf D.J., et al. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc Natl Acad Sci USA 2001, 98:507-512.
69. Liang Y., Lin S., Beyer T.P., Zhang Y., Wu X., Bales K.R., et al. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes. J Neurochem 2004, 88:623-634.
70. Xu N., Dahlback B. A novel human apolipoprotein (apoM). J Biol Chem 1999, 274:31286-31290.
71. Wolfrum C., Poy M.N., Stoffel M. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med Nat Med 2005, 11:418-422.
72. Zhang X., Zhu Z., Luo G., Zheng L., Nilsson-Ehle P., Xu N. Liver X receptor agonist downregulates hepatic apoM expression in vivo and in vitro. Biochem Biophys Res Commun 2008, 371:114-117.
73. Calayir E., Becker T.M., Kratzer A., Ebner B., Panzenböck U., Stefujl J., et al. LXR-agonists regulate ApoM expression differentially in liver and intestine. Curr Pharm Biotechnol 2008, 9:516-521.
74. Osono Y., Woollett L.A., Herz J., Dietschy J.M. Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse. J Clin Invest 1995, 95:1124-1132.
75. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232:34-47.
76. Rigotti A., Miettinen H.E., Krieger M. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr Rev 2003, 24:357-387.
77. Wiersma H, Gatti A, Nijstad N, Oude Elferink RP Kuipers F, Tietge UJ Scavenger receptor class B type I mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5/g8 in mice. Hepatology 2009, Epub ahead of print.
78. Rowe A.H., Argmann C.A., Edwards J.Y., Sawyez C.G., Morand O.H., Hegele R.A., et al. Enhanced synthesis of the oxysterol 24(S), 25-epoxycholesterol in macrophages by inhibitors of 2, 3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation. Circ Res 2003, 93:717-725.
79. Masson D., Staels B., Gautier T., Desrumaux C., Athias A., Le Guern N., et al. Cholesteryl ester transfer protein modulates the effect of liver X receptor agonists on cholesterol transport and excretion in the mouse. J Lipid Res 2004, 45:543-550.
80. Ishimoto K, Tachibana K, Sumitomo M, Omote S, Hanano I, Yamasaki D, et al. Identification of human low-density lipoprotein receptor as a novel target gene regulated by liver X receptor alpha. FEBS Lett 2006, 580:4929-4933.
81. Zelcer N., Hong C., Boyadjian R., Tontonoz P. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 2009, 325:100-104.
82. Malerød L., Juvet L.K., Hanssen-Bauer A., Eskild W., Berg T. Oxysterol-activated LXRalpha/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes. Biochem Biophys Res Commun 2002, 299:916-923.
83. Norata G.D., Ongari M., Uboldi P., Pellegatta F., Catapano A.L. Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells. Int J Mol Med 2005, 16:717-722.
84. Davis R.A., Miyake J.H., Hui T.Y., Spann N.J. Regulation of cholesterol-7alpha-hydroxylase: BAREly missing a SHP. J Lipid Res 2002, 43:533-543.
85. Peet D.J., Turley S.D., Ma W., Janowski B.A., Lobaccaro J.M., Hammer R.E., et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998, 93:693-704.
86. Lehmann J.M., Kliewer S.A., Moore L.B., Smith-Oliver T.A., Oliver B.B., Su J.L., et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 1997, 272:3137-3140.
87. Chiang J.Y., Kimmel R., Stroup D. Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). Gene 2001, 262:257-265.
88. Uppal H., Saini S.P., Moschetta A., Mu Y., Zhou J., Gong H., et al. Activation of LXRs prevents bile acid toxicity and cholestasis in female mice. Hepatology 2007, 45:422-432.
89. Giguére V., Tini M., Flock G., Ong E., Evans R.M., Otulakowski G. Isoform-specific amino-terminal domains dictate DNA-binding properties of RORα, a novel family of orphan hormone nuclear receptors. Genes Dev 1994, 8:538-553.
90. Wada T., Kang H.S., Angers M., Gong H., Bhatia S., Khadem S., et al. Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene and a functional cross-talk between RORalpha and liver X receptor (NR1H3). Mol Pharmacol 2008, 73:891-899.
91. Langdon R.G., Bloch K. The effect of some dietary additions on the synthesis of cholesterol from acetate in vitro. J Biol Chem 1953, 202:77-81.
92. Brown M.S., Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997, 89:331-340.
93. Greenspan M.D., Yudkovitz J.B., Lo C.Y., Chen J.S., Alberts A.W., Hunt V.M., et al. Inhibition of hydroxymethylglutaryl-coenzyme A synthase by L-659, 699. Proc Natl Acad Sci U S A 1987, 84:7488-7492.
94. Eckert G.P., Vardanian L., Rebeck G.W., Burns M.P. Regulation of central nervous system cholesterol homeostasis by the liver X receptor agonist TO-901317. Neurosci Lett 2007, 423:47-52.
95. Tzotzas T., Desrumaux C., Lagrost L. Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor. Obes Rev 2009, 10:403-411.
96. Ooi E.M., Watts G.F., Ji J., Rye K.A., Johnson A.G., Chan D.C., et al. Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo. Clin Endocrinol (Oxf) 2006, 65:752-759.
97. Barter P.J. Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors. Atheroscler Suppl 2002, 3:39-47.
98. Laffitte B.A., Joseph S.B., Chen M., Castrillo A., Repa J., Wilpitz D., et al. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions. Mol Cell Biol 2003, 23:2182-2191.
99. Cao G., Beyer T.P., Yang X.P., Schmidt R.J., Zhang Y., Bensch W.R., et al. Phospholipid transfer protein is regulated by liver X receptors in vivo. J Biol Chem 2002, 277:39561-39565.
100. Luo Y., Tall A.R. Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J Clin Invest 2000, 105:513-520.